In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

EST Psyence Biomedical (PBM) files to sell 3.075M common shares for holdersInvest with Confidence: Follow TipRanks' Top Wall Street ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...